2007 American Heart Association Scientific Sessions Leadership Summit

A Panel Discussion among Six General and Interventional Cardiologists

November 2007

Study Description and Objectives

§    The CORONA trial involving Rosuvastatin in heart failure patients  

§    The ILLUMINATE trial involving Torceptrapib, a CETP inhibitor  

§    Extended release Niacin/Laropiprant

§    The TRITON-TIMI 38 study about Prasugrel 

§    The EVA-AMI and BRIEF-PCI studies about Integrilin® (eptifibatide)

§    SCH 530348, a thrombin receptor

§    CYT006-AngQb, a vaccine to treat hypertension

§    The COURAGE sub-study trial

§    Cangrelor, a rapidly acting intravenous ADP-antagonist

Companies and Products Mentioned in This Report

 Inclusion Criteria and Panelist Demographics

Hospitals Represented

To purchase this report or request additional information, contact:

Reports become free one year after the publication date.